Gene · 11004
Papers1,860
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,860
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of a novel prognostic signature and key genes related to development of anaplastic thyroid carcinoma. | Discov Oncol | 2024 | 39562412 | PubTator, text mining | PubMed |
| Identification and Validation of Telomere-Related Gene Signature in Intervertebral Disc Degeneration. | Cureus | 2024 | 39553152 | PubTator, text mining | PubMed |
| Genome-wide binding analysis unveils critical implication of B-Myb-mediated transactivation in cancers. | Int J Biol Sci | 2024 | 39309447 | PubTator, text mining | PubMed |
| Transcriptomic landscape of quiescent and proliferating human corneal stromal fibroblasts. | Exp Eye Res | 2024 | 39243928 | PubTator, text mining | PubMed |
| Molecular Alterations Associated with Histologically Overt Stromal Response in Patients with Prostate Cancer. | Int J Mol Sci | 2024 | 39201599 | PubTator, text mining | PubMed |
| Modeling study of kinesin-13 MCAK microtubule depolymerase. | Eur Biophys J | 2024 | 39093405 | PubTator, text mining | PubMed |
| Identification of novel biomarkers and potential molecular targets for uterine cancer using network-based approach. | Pathol Res Pract | 2024 | 39029376 | PubTator, text mining | PubMed |
| KIF2C as a potential therapeutic target: insights from lung adenocarcinoma subtype classification and functional experiments. | Mol Omics | 2024 | 38940931 | PubTator, text mining | PubMed |
| Vesicle-mediated transport-related genes predict the prognosis and immune microenvironment in hepatocellular carcinoma. | J Cancer | 2024 | 38911369 | PubTator, text mining | PubMed |
| DNA damage response-related signatures characterize the immune landscape and predict the prognosis of HCC via integrating single-cell and bulk RNA-sequencing. | Int Immunopharmacol | 2024 | 38909498 | PubTator, text mining | PubMed |
| Deciphering the miRNA-mRNA Interaction Landscape between Breast Cancer and Triple-Negative Breast Cancer: An Integrated Bioinformatics Approach. | ACS Omega | 2024 | 38882157 | PubTator, text mining | PubMed |
| Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells. | Cancer Discov | 2024 | 38587317 | PubTator, text mining | PubMed |
| Constructing lactylation-related genes prognostic model to effectively predict the disease-free survival and treatment responsiveness in prostate cancer based on machine learning. | Front Genet | 2024 | 38566813 | PubTator, text mining | PubMed |
| Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment. | Med Oncol | 2024 | 38526604 | PubTator, text mining | PubMed |
| Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A review. | Comput Struct Biotechnol J | 2024 | 38510977 | PubTator, text mining | PubMed |
| Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction. | Cell Death Dis | 2024 | 38493150 | PubTator, text mining | PubMed |
| The platelet-related genes associated with the prognosis of HCC by regulating cycling T cell and prolif-TAMs. | Heliyon | 2024 | 38486758 | PubTator, text mining | PubMed |
| Regulation and tumor-suppressive function of the miR-379/miR-656 (C14MC) cluster in cervical cancer. | Mol Oncol | 2024 | 38400534 | PubTator, text mining | PubMed |
| CSPP1 stabilizes microtubules by capping both plus and minus ends. | J Mol Cell Biol | 2024 | 38389254 | PubTator, text mining | PubMed |
| KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker. | Crit Rev Clin Lab Sci | 2024 | 38344808 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11004/papers?page=5